Detalhe da pesquisa
1.
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
Lancet
; 402(10419): 2307-2316, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979595
2.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516125
3.
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Cephalalgia
; 51(8): 3331024231190296, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638400
4.
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis.
Headache
; 63(8): 1135-1144, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655536
5.
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
Cephalalgia
; 41(9): 979-990, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33874756
6.
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
Headache
; 60(4): 686-700, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073660
7.
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
Headache
; 60(1): 141-152, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913519
8.
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain.
Neurology
; 99(17): e1905-e1915, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977836
9.
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease.
Alzheimers Dement
; 7(4): 425-35, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21646051
10.
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials.
Neurol Ther
; 10(1): 235-249, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608814
11.
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Am J Psychiatry
; 175(1): 71-79, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28946761